RecruitingNot ApplicableNCT05989854

The Remote Study: Investigating the Effects or Online Exercise on Quality of Life in Men With Prostate Cancer

An Individualised 8-week Remote Exercise Intervention to Improve QoL, Cardiometabolic Risk and Physical Activity Level in Men With Prostate Cancer Undergoing ADT Treatment.

Sponsor

University of Surrey

Enrollment

50 participants

Start Date

Apr 1, 2024

Study Type

INTERVENTIONAL

Conditions

Prostate Cancer

Summary

Currently, there are few opportunities for patients with cancer to have individual exercise guidance, and this has further been impacted by the Covid-19 pandemic. However, during the pandemic the use of virtual/remote platforms has been crucial in delivering care to cancer patients. The investigators think that remote exercise training may also offer a solution to support positive change in prostate cancer patients. As a result, the investigators have developed a remote/online exercise programme to explore this further. This study will explore the effectiveness of an 8-week remote exercise and behavioural support intervention, and whether prostate cancer patients feel they benefit from this. The study also aims to see if this sort of exercise programme can be delivered to more prostate cancer patients in the future. This project is open to men with prostate cancer on long term hormone therapy. The intervention will be comprised of one remote supervised session per week, completed 1-1 using an online platform and up to two additional sessions, depending on its suitability for the patient, will be prescribed as unsupervised home-based exercise.

Eligibility

Sex: MALEMin Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether an online (remote) exercise program can improve quality of life, reduce fatigue, and support the well-being of men with prostate cancer who are on long-term hormone-suppressing therapy (androgen deprivation therapy or related drugs). **You may be eligible if...** - You have prostate cancer and have had an orchiectomy (surgical removal of testicles), OR - You are receiving a GnRH agonist/antagonist, OR - You are on abiraterone, enzalutamide, apalutamide, or darolutamide - You plan to remain on these treatments for at least 6 more months **You may NOT be eligible if...** - You are currently in active cancer treatment (such as chemotherapy or radiation) - You are not on long-term hormone-based therapy - You do not plan to continue treatment for at least 6 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.